跳至主要内容
临床试验/NCT04850742
NCT04850742Unknown不适用

Feasibility of Tracheobronchial Reconstruction Using Bioengineered Aortic Matrices

National Taiwan University Hospital1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2019年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
5
试验地点
1
主要终点
90-day mortality

研究概览

简要总结

We used a segment of cryopreserved aorta as a graft for reconstruction for long segment tracheobronchial lesion in human.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with advanced benign or malignant lesions involving trachea or bronchi, and has failed conventional treatment.
  • •Patients with proximal pulmonary tumors that require surgical resection and has involved proximal airways which is indicated for a pneumonectomy, sleeve lobectomy, or carina resection.

排除标准

  • •Less than 20-year-old
  • •Unable to obtain informed consent.
  • •Pulmonary tumors that can be treated with standard lobectomy.
  • •Unresectable locally advanced malignant tumors
  • •Malignant tumors with contralateral lymph nodes involvement.
  • •Malignant tumors with distal metastases; except for simple resectable brain metastasis.
  • •Tracheal lesions which can be treated with standard resection and direct anastomosis.
  • •Allergic to iodine
  • •Unable to tolerate standard lobectomy
  • •Has human immunodeficiency virus infection
  • •Tracheal stenosis at proximal 2 cm on upper trachea

研究组 & 干预措施

Cryopreserved aorta

Experimental

After resection of a segment of tracheal or bronchial lesion, reconstruct the airway with cryopreserved aortic allograft.

干预措施: Cryopreserved aorta (Procedure)

结局指标

主要结局

90-day mortality

时间窗: 90 days

The rate of death at 90 days.

次要结局

  • 90-day morbidity(90 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验